Home » Topics » Infection » Coronavirus

Coronavirus
RSS

AVI Brings In $23M For Third-Generation Antisense Drugs

Nov. 16, 2005

Other News To Note

Nov. 3, 2005

Collaborations Between Biotech And Pharmaceutical Companies: Aug. 19-Oct. 19, 2005

Oct. 24, 2005

New SARS Target Discoveries;Fresh Therapeutic Approaches

Sep. 19, 2005

By Anette Breindl

Analysts: Interest In Antisense Waning, But Science Not Dead

Sep. 16, 2005

Other News To Note

Sep. 13, 2005

Other News To Note

July 20, 2005

ACE2 Receptor Is New Drug Target In SARS Lung Failure

July 13, 2005

By Sharon Kingman

Found Coronavirus Might Have Ties To Pediatric Heart Disease

Feb. 11, 2005

By Anette Breindl

Driving A Spike Through Heart Of SARS Proving Challenging

Jan. 18, 2005

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.